查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386152

瘧疾疫苗市場報告：2030 年趨勢、預測與競爭分析

Malaria Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

瘧疾疫苗趨勢與預測

預計到 2030 年，全球瘧疾疫苗市場將達到 69 億美元，2024 年至 2030 年複合年成長率為 18.6%。該市場的主要驅動力是對瘧疾疫苗的需求不斷成長、前紅血球生成疫苗的出現以及對疫苗輸送平台的日益偏好。全球瘧疾疫苗市場前景看好，醫院、專科診所和居家醫療市場都有商機。

瘧疾疫苗市場洞察

Lucintel 預測，在預測期內，前紅血球預計將經歷最高的成長。

在這個市場中，預計醫院將在預測期內實現最高成長。

由於其強大的醫療基礎設施、疫苗研發的高投資以及主要製造商的存在，北美仍然是最大的地區。

市場規模/估計：以金額的估計瘧疾疫苗市場規模（10 億美元）。

趨勢和預測分析：各個區隔市場和地區的市場趨勢（2018-2023）和預測（2024-2030）。

區隔分析：依類型、藥物、最終用途和地區金額（十億美元）估計瘧疾疫苗市場規模。

區域分析：北美、歐洲、亞太地區以及世界其他地區、中東和非洲的瘧疾疫苗市場區隔。

成長機會：依類型、藥物、最終用途和地區分類的瘧疾疫苗市場成長機會分析。

策略分析：瘧疾疫苗市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球瘧疾疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球瘧疾疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 全球瘧疾疫苗市場（依類型）
    • 前紅血球
    • 紅血球
    • 多種抗原
    • 其他
  • 依藥物分類的全球瘧疾疫苗市場
    • 惡性瘧原蟲
    • 間日瘧原蟲
    • 依蚊種
  • 全球瘧疾疫苗市場（依最終用途）
    • 醫院
    • 專科診所
    • 居家醫療
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球瘧疾疫苗市場區域分佈
  • 北美瘧疾疫苗市場
  • 歐洲瘧疾疫苗市場
  • 亞太瘧疾疫苗市場
  • 其他區域瘧疾疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依類型分類的全球瘧疾疫苗市場成長機會
    • 全球瘧疾疫苗市場藥物成長機會
    • 全球瘧疾疫苗市場成長機會（依最終用途）
    • 全球瘧疾疫苗市場成長機會（依地區）
  • 全球瘧疾疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球瘧疾疫苗市場產能擴張
    • 全球瘧疾疫苗市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Actiza Pharmaceutical
  • AdvaCare Pharma
  • Ipca Laboratories
  • Bliss GVS Pharma
  • GeoVax
  • Sumaya Biotech
  • VLP Therapeutics
  • OSIVAX
  • AJANTA PHARMA
  • Strides Pharma Science
簡介目錄

Malaria Vaccine Trends and Forecast

The future of the global malaria vaccine market looks promising with opportunities in the hospital, specialty clinic, and homecare markets. The global malaria vaccine market is expected to reach an estimated $6.9 billion by 2030 with a CAGR of 18.6% from 2024 to 2030. The major drivers for this market are growing demand for malaria vaccines, emergence of pre-erythrocytic vaccines, and rising preference for vaccine delivery platforms.

A more than 150-page report is developed to help in your business decisions.

Malaria Vaccine by Segment

The study includes a forecast for the global malaria vaccine by type, agent, end use, and region.

Malaria Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Pre-Erythrocytic
  • Erythrocytic
  • Multi-Antigen
  • Others

Malaria Vaccine Market by Agent [Shipment Analysis by Value from 2018 to 2030]:

  • Plasmodium Falciparum
  • Plasmodium Vivax
  • Anopheles Species

Malaria Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Malaria Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Malaria Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies malaria vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the malaria vaccine companies profiled in this report include-

  • Actiza Pharmaceutical
  • AdvaCare Pharma
  • Ipca Laboratories
  • Bliss GVS Pharma
  • GeoVax
  • Sumaya Biotech
  • VLP Therapeutics
  • OSIVAX
  • AJANTA PHARMA
  • Strides Pharma Science

Malaria Vaccine Market Insights

Lucintel forecasts that pre-erythrocytic is expected to witness highest growth over the forecast period.

Within this market, hospital is expected to witness highest growth over the forecast period.

North America will remain the largest region due to existence of robust healthcare infrastructure, high investment in vaccines research and development, and presence of key manufacturers in the region.

Features of the Global Malaria Vaccine Market

Market Size Estimates: Malaria vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Malaria vaccine market size by type, agent, end use, and region in terms of value ($B).

Regional Analysis: Malaria vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, agents, end uses, and regions for the malaria vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the malaria vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the malaria vaccine market size?

Answer: The global malaria vaccine market is expected to reach an estimated $6.9 billion by 2030.

Q.2 What is the growth forecast for malaria vaccine market?

Answer: The global malaria vaccine market is expected to grow with a CAGR of 18.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the malaria vaccine market?

Answer: The major drivers for this market are growing demand for malaria vaccines, emergence of pre-erythrocytic vaccines, and rising preference for vaccine delivery platforms.

Q4. What are the major segments for malaria vaccine market?

Answer: The future of the malaria vaccine market looks promising with opportunities in the hospital, specialty clinic, and homecare markets.

Q5. Who are the key malaria vaccine market companies?

Answer: Some of the key malaria vaccine companies are as follows:

  • Actiza Pharmaceutical
  • AdvaCare Pharma
  • Ipca Laboratories
  • Bliss GVS Pharma
  • GeoVax
  • Sumaya Biotech
  • VLP Therapeutics
  • OSIVAX
  • AJANTA PHARMA
  • Strides Pharma Science

Q6. Which malaria vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that pre-erythrocytic is expected to witness highest growth over the forecast period.

Q7. In malaria vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure, high investment in vaccines research and development, and presence of key manufacturers in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the malaria vaccine market by type (pre-erythrocytic, erythrocytic, multi-antigen, and others), agent (plasmodium falciparum, plasmodium vivax, and anopheles species), end use (hospitals, specialty clinics, homecare, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Malaria Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Malaria Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Malaria Vaccine Market by Type
    • 3.3.1: Pre-Erythrocytic
    • 3.3.2: Erythrocytic
    • 3.3.3: Multi-Antigen
    • 3.3.4: Others
  • 3.4: Global Malaria Vaccine Market by Agent
    • 3.4.1: Plasmodium Falciparum
    • 3.4.2: Plasmodium Vivax
    • 3.4.3: Anopheles Species
  • 3.5: Global Malaria Vaccine Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Specialty Clinics
    • 3.5.3: Homecare
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Malaria Vaccine Market by Region
  • 4.2: North American Malaria Vaccine Market
    • 4.2.2: North American Malaria Vaccine Market by End Use: Hospitals, Specialty Clinics, Homecare, and Others
  • 4.3: European Malaria Vaccine Market
    • 4.3.1: European Malaria Vaccine Market by Type: Pre-Erythrocytic, Erythrocytic, Multi-Antigen, and Others
    • 4.3.2: European Malaria Vaccine Market by End Use: Hospitals, Specialty Clinics, Homecare, and Others
  • 4.4: APAC Malaria Vaccine Market
    • 4.4.1: APAC Malaria Vaccine Market by Type: Pre-Erythrocytic, Erythrocytic, Multi-Antigen, and Others
    • 4.4.2: APAC Malaria Vaccine Market by End Use: Hospitals, Specialty Clinics, Homecare, and Others
  • 4.5: ROW Malaria Vaccine Market
    • 4.5.1: ROW Malaria Vaccine Market by Type: Pre-Erythrocytic, Erythrocytic, Multi-Antigen, and Others
    • 4.5.2: ROW Malaria Vaccine Market by End Use: Hospitals, Specialty Clinics, Homecare, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Malaria Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Malaria Vaccine Market by Agent
    • 6.1.3: Growth Opportunities for the Global Malaria Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Malaria Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Malaria Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Malaria Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Malaria Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Actiza Pharmaceutical
  • 7.2: AdvaCare Pharma
  • 7.3: Ipca Laboratories
  • 7.4: Bliss GVS Pharma
  • 7.5: GeoVax
  • 7.6: Sumaya Biotech
  • 7.7: VLP Therapeutics
  • 7.8: OSIVAX
  • 7.9: AJANTA PHARMA
  • 7.10: Strides Pharma Science